32 MMWR June 18, <strong>2010</strong> 509. Joshi JV, Joshi UM, Sankholi GM, et al. A study of interaction of lowdose combination oral contraceptive with ampicillin and metronidazole. Contraception 1980;22:643–52. 510. Kakouris H, Kovacs GT. Pill failure and nonuse of secondary precautions. Br J Fam Plann 1992;18:41–4. 511. Kakouris H, Kovacs GT. How common are predisposing factors to pill failure among pill users? Br J Fam Plann 1994;20:33–5. 512. Kovacs GT, Riddoch G, Duncombe P, et al. Inadvertent pregnancies in oral contraceptive users. Med J Aust 1989;150:549–51. 513. Lequeux A. Pregnancy under oral contraceptives after treatment with tetracycline] [in French]. Louv Med 1980;99:413–4. 514. London BM, Lookingbill DP. Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives. Arch Dermatol 1994;130:392–3. 515. Maggiolo F, Puricelli G, Dottorini M, et al. The effects of ciprofloxacin on oral contraceptive steroid treatments. Drugs Exp Clin Res 1991;17:451–4. 516. Murphy AA, Zacur HA, Charache P, Burkman RT. The effect of tetracycline on levels of oral contraceptives. Am J Obstet Gynecol 1991;164:28–33. 517. Neely JL, Abate M, Swinker M, D’Angio R. The effect of doxycycline on serum levels of ethinyl estradiol, noretindrone, and endogenous progesterone. Obstet Gynecol 1991;77:416–20. 518. Pillans PI, Sparrow MJ. Pregnancy associated with a combined oral contraceptive and itraconazole [comment]. N Z Med J 1993;106:436. 519. Scholten PC, Droppert RM, Zwinkels MG, et al. No interaction between ciprofloxacin and an oral contraceptive. Antimicrob Agents Chemother 1998;42:3266–8. 520. Silber TJ. Apparent oral contraceptive failure associated with antibiotic administration. J Adolesc Health Care 1983;4:287–9. 521. Sparrow MJ. Pill method failures. N Z Med J 1987;100:102–5. 522. Sparrow MJ. Pregnancies in reliable pill takers. N Z Med J 1989;102:575–7. 523. Sparrow MJ. Pill method failures in women seeking abortion—fourteen years experience. N Z Med J 1998;111:386–8. 524. van Dijke CP, Weber JC. Interaction between oral contraceptives and griseofulvin. Br Med J (Clin Res Ed) 1984;288:1125–6. 525. Wermeling DP, Chandler MH, Sides GD, Collins D, Muse KN. Dirithromycin increases ethinyl estradiol clearance without allowing ovulation. Obstet Gynecol 1995;86:78–84. 526. Young LK, Farquhar CM, McCowan LM, Roberts HE, Taylor J. The contraceptive practices of women seeking termination of pregnancy in an Auckland clinic. N Z Med J 1994;107:189–92. 527. Abrams LS, Skee D, Natarajan J, Wong FA. Pharmocokinetic overview of Ortho Evra/Evra. Fertil Steril 2002;77:s3–s12. 528. Dogterom P, van den Heuvel MW, Thomsen T. Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomized trials. Clin Pharmacokinet 2005;44:429–38. 529. Devenport MH, Crook D, Wynn V, Lees LJ. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives. Br J Clin Pharmacol 1989;27:851–9. 530. Hilbert J, Messig M, Kuye O. Evaluation of interaction between fluconazole and an oral contraceptive in healthy women. Obstet Gynecol 2001;98:218–23. 531. Kovacs I, Somos P, Hamori M. Examination of the potential interaction between ketoconazole (Nizoral) and oral contraceptives with special regard to products of low hormone content (Rigevidon, anteovin). Ther Hung 1986;34:167–70. 532. Lunell NO, Pschera H, Zador G, Carlstrom K. Evaluation of the possible interaction of the antifungal triazole SCH 39304 with oral contraceptives in normal health women. Gynecol Obstet Invest 1991;32:91–7. 533. McDaniel PA, Cladroney RD. Oral contraceptives and griseofulvin interactions. Drug Intell Clin Pharm 1986;20:384. 534. Meyboom RH, van Puijenbroek EP, Vinks MH, Lastdrager CJ. Disturbance of withdrawal bleeding during concomitant use of itraconazole and oral contraceptives. N Z Med J 1997;110:300. 535. Rieth H, Sauerbrey N. Interaction studies with fluconazole, a new tirazole antifungal drug [in German]. Wien Med Wochenschr 1989;139:370–4. 536. Sinofsky FE, Pasquale SA. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. Am J Obstet Gynecol 1998;178:300–4. 537. van Puijenbroek EP, Feenstra J, Meyboom RH. Pill cycle disturbance in simultaneous use of itraconazole and oral contraceptives [in Dutch]. Ned Tijedschr Geneeskd 1998;142:146–9. 538. van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG. Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Br J Clin Pharmacol 1999;47:689–93. 539. Verhoeven CH, van den Heuvel MW, Mulders TM, Dieben TO. The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication. Contraception 2004;69:129–32. 540. Back DJ, Breckenridge AM, Grimmer SF, Orme ML, Purba HS. Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine. Contraception 1984;30:289–95. 541. Croft AM, Herxheimer A. Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? BMC Public Health 2002;2:6. 542. Karbwang J, Looareesuwan S, Back DJ, Migasana S, Bunnag D. Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women. Bull World Health Organ 1988;66:763–7. 543. McGready R, Stepniewska K, Seaton E, et al. Pregnancy and use of oral contaceptives reduces the biotrans<strong>for</strong>mation of proguanil to cycloguanil. Eur J Clin Pharmacol 2003;59:553–7. 544. Wanwimolruk S, Kaewvichit S, Tanthayaphinant O, Suwannarach C, Oranratnachai A. Lack of effect of oral contraceptive use on the pharmacokinetics of quinine. Br J Clin Pharmacol 1991;31:179–81. 545. Back DJ, Breckenridge AM, Craw<strong>for</strong>d FE, et al. The effect of rifampicin on norethisterone pharmacokinetics. Eur J Clin Pharmacol 1979;15:193–7. 546. Back DJ, Breckenridge AM, Craw<strong>for</strong>d FE, et al. The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women. Contraception 1980;21:135–43. 547. Barditch-Crovo P, Trapnell CB, Ette E, et al. The effects of rifampicin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clin Pharmacol Ther 1999;65:428–38. 548. Bolt HM, Bolt M, Kappus H. Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Acta Endocrinol (Copenh) 1977;85:189–97. 549. Gupta KC, Ali MY. Failure of oral contraceptive with rifampicin. Med J Zambia 1981;15:23. 550. Hirsch A. Sleeping pills [letter] [in French]. Nouv Presse Med 1973;2:2957.
Vol. 59 / RR-4 Recommendations and Reports 33 551. Hirsch A, Tillement JP, Chretien J. Effets contrariants de la rifampicine sur les contraceptifs oraux: a propos de trois grossesses non desiree chez trois malades. Rev Fr Mal Respir 1975;2:174–82. 552. Joshi JV, Joshi UM, Sankholi GM, et al. A study of interaction of a low-dose combination oral contraceptive with anti-tubercular drugs. Contraception 1980;21:617–29. 553. Kropp R. Rifampicin and oral cotnraceptives (author’s transl) [in German]. Prax Pneumol 1974;28:270–2. 554. LeBel M, Masson E, Guilbert E, et al. Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone. J Clin Pharmacol 1998;38:1042–50. 555. Meyer B, Muller F, Wessels P, Maree J. A model to detect interactions between roxithromycin and oral contraceptives. Clin Pharmacol Ther 1990;47:671–4. 556. Nocke-Finke L, Breuer H, Reimers D. Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives [in German]. Deutsche Med Wochenschr 1973;98:1521–3. 557. Piguet B, Muglioni JF, Chaline G. Oral contraception and rifampicin [letter] [in French]. Nouv Presse Med 1975;4:115–6. 558. Reimers D, Jezek A. The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives [in German]. Prax Pneumol 1971;25:255–62. 559. Skolnick JL, Stoler BS, Katz DB, Anderson WH. Rifampicin, oral contraceptives, and pregnancy. JAMA 1976;236:1382. 560. Szoka PR, Edgren RA. Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database. Fertil Steril 1988;49:s31–s38.
Change language